Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay
- PMID: 23518063
- DOI: 10.1016/j.vascn.2013.03.001
Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay
Abstract
Introduction: Cardiac safety is of paramount importance in contemporary drug development. Efficient and sensitive evaluation of cardiac safety in the research and development of new molecular agents begins with preclinical in-vitro models. A new model that is currently under evaluation is the human embryonic stem-cell derived cardiac myocytes (hESC-CM) (Peng, Lacerda, Kirsch, Brown, & Bruening-Wright, 2010).
Methods: hESC-CM were exposed in-vitro to 15 test compounds, and action potentials (AP) recorded with perforated patch-clamp technique to assess changes in AP duration (APD90) and upstroke velocity (Vmax). The test compounds included: 10 hERG channel, 4 Na⁺ channel, and 1 IKs channel inhibitors. For comparison purposes, the test compounds were evaluated in the isolated rabbit heart assay (IRH) to determine changes in conduction (QRS) and repolarization (QTc). Potency at hERG, NaV1.5 and IKs channel was also determined.
Results: For 7 of 10 hERG channel inhibitors, the potency values across the three functional assays were similar (≤5-fold). Three compounds (dofetilide, sertindole, and terfenadine) showed >10-fold discrepancy between hERG potency and inhibitory concentrations in the hESC-CM and IRH assays. Of the four Na⁺ channel inhibitors, only mexiletine exhibited similar potency values across the three assays (~3-fold); the others exhibited marked variation (>10-fold) in inhibitory potency. No effect on repolarization was observed in hESC-CM treated with a potent IKs blocker, but QTc prolongation was evident in the IRH.
Discussion: The functional data indicate that hESC-CM are sensitive for detecting repolarization delay induced by hERG channel blockade, and AP prolongation correlated with potency in the hERG channel and IRH assays. However, hESC-CM were less sensitive for detecting depolarizing delay by Na⁺ channel blockers, and unable to detect delayed repolarization caused by IKs blockade.
Keywords: APD90; Human embryonic stem cells derived cardiac myocytes; Isolated rabbit heart; Patch-clamp method; QRS intervals; QTc intervals.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.J Cardiovasc Electrophysiol. 2004 Nov;15(11):1302-9. doi: 10.1046/j.1540-8167.2004.04099.x. J Cardiovasc Electrophysiol. 2004. PMID: 15574182
-
Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.J Mol Cell Cardiol. 2012 May;52(5):998-1008. doi: 10.1016/j.yjmcc.2012.02.002. Epub 2012 Feb 14. J Mol Cell Cardiol. 2012. PMID: 22353256
-
Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.PLoS One. 2018 Apr 9;13(4):e0195577. doi: 10.1371/journal.pone.0195577. eCollection 2018. PLoS One. 2018. PMID: 29630634 Free PMC article.
-
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.Cardiovasc Res. 2003 Apr 1;58(1):32-45. doi: 10.1016/s0008-6363(02)00846-5. Cardiovasc Res. 2003. PMID: 12667944 Review.
-
QT interval prolongation and cardiac risk assessment for novel drugs.Curr Opin Investig Drugs. 2003 Mar;4(3):303-8. Curr Opin Investig Drugs. 2003. PMID: 12735231 Review.
Cited by
-
Transformative Potential of Induced Pluripotent Stem Cells in Congenital Heart Disease Research and Treatment.Children (Basel). 2025 May 23;12(6):669. doi: 10.3390/children12060669. Children (Basel). 2025. PMID: 40564627 Free PMC article. Review.
-
Action Potential Recording and Pro-arrhythmia Risk Analysis in Human Ventricular Trabeculae.Front Physiol. 2018 Jan 5;8:1109. doi: 10.3389/fphys.2017.01109. eCollection 2017. Front Physiol. 2018. PMID: 29354071 Free PMC article.
-
Evolution of strategies to improve preclinical cardiac safety testing.Nat Rev Drug Discov. 2016 Jul;15(7):457-71. doi: 10.1038/nrd.2015.34. Epub 2016 Feb 19. Nat Rev Drug Discov. 2016. PMID: 26893184 Review.
-
Adult Human Primary Cardiomyocyte-Based Model for the Simultaneous Prediction of Drug-Induced Inotropic and Pro-arrhythmia Risk.Front Physiol. 2017 Dec 19;8:1073. doi: 10.3389/fphys.2017.01073. eCollection 2017. Front Physiol. 2017. PMID: 29311989 Free PMC article.
-
Human ex-vivo action potential model for pro-arrhythmia risk assessment.J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:183-95. doi: 10.1016/j.vascn.2016.05.016. Epub 2016 May 25. J Pharmacol Toxicol Methods. 2016. PMID: 27235787 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous